About Pentagon Labs
Pentagon Labs is a Healthcare company based in Dewas (India) founded in 2002 by M L Jain. Research laboratory focused on developing manufacturing quality drugs formulations. Pentagon Labs has raised $1.36 million across 1 funding round from investors including Leo S M Finance, Mittal Warehousing and Cargo and Leo Corporate Consultants Indore. Pentagon Labs was last valued at $34.16 million in March 2014. Its Indian entity Pentagon Labs Limited reported revenue of ₹76.72 Cr. Pentagon Labs offers products and services including Infusion Therapy and Antibiotics and Antifungal. Its focus areas include Medical Research Labs.
Company details
Pentagon Labs research laboratory focused on developing manufacturing quality drugs formulations through providing healthcare solutions, and medical research labs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Dewas, India
- Founders M L Jain
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pentagonlabsltd.com
- Legal Name Pentagon Labs Limited
- Date of Incorporation 20 Oct, 1994
- Jurisdiction Indore, Madhya Pradesh, India
- Annual Revenue₹76.72 Cr
FY 2025 · +8% YoY
- Net Profit₹5.07 Cr
FY 2025 · 7% margin
- EBITDA₹9.78 Cr
FY 2025 · 13% margin
- Total Equity Funding$1.36M (USD)
in 1 rounds
- Latest Funding Round$1.36M (USD), Series A
Mar 2014
Associated legal entities of Pentagon Labs
Pentagon Labs operates through Pentagon Labs Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pentagon Labs Limited CIN U27201MP1994PLC008738 | Active | 20 Oct 1994 | Indore, Madhya Pradesh | ₹76.7 Cr | 7 | View details |
Products & Services of Pentagon Labs
Pentagon Labs offers a comprehensive portfolio of products and services, including Infusion Therapy and Antibiotics and Antifungal.
Infusion therapy products are manufactured for various therapeutic segments to support critical care needs.
Antibiotics and antifungal drugs are developed for treating infections and are supplied across medical applications.
Funding Insights of Pentagon Labs
Pentagon Labs has successfully raised a total of $1.36M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.36 million completed in March 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.36M
- Total Rounds 1
- Last Round Series A — $1.36M
- First Round $1.36M
(Mar 2014)
- Investors Count 5
All 1 funding rounds of Pentagon Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2014 | $1.36M | Series A | $34.16M | Leo S M Finance, Leo Corporate Consultants Indore |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2014 | $34.16M | •••••••• |
Last known valuation $34.16M (Mar 2014). 5 investors in total: 3 institutional and 2 angel.
Investors in Pentagon Labs
Pentagon Labs has secured backing from 5 investors, including institutional and angel investors. Prominent investors backing the company include Leo S M Finance, Mittal Warehousing and Cargo and Leo Corporate Consultants Indore.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Consumer and SME loans are provided to clients in India. | leosmfinance.tcc.mode | Indore, India | ||
| mittalwarehousingandcargo.tcc.mode | ||||
| leocorporateconsultantsindore.tcc.mode | ||||
SM Shobhna Mittal | unknown_ed9339162c2941198 | |||
MC Mahesh Chand Mittal | unknown_2ac5800fbc444fae8 |
Investor details for Pentagon Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Pentagon Labs Limited (Pentagon Labs)
Pentagon Labs Limited is the primary company behind Pentagon Labs. The board of Pentagon Labs Limited currently have 6 directors; the longest-serving is Sanjeev Kumar Jain, appointed in 2003. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjeev Kumar Jain DIN 00011407 | Director | 19 Apr 2003 | 23 yrs 6 mo | Pentagon Labs Limited |
| Munna Lal Jain DIN 00090382 | Director | 19 Apr 2003 | 23 yrs 6 mo | Pentagon Labs Limited |
| Mahesh Chand Mittal DIN 00090544 | Director | 30 Sep 2005 | 21 yrs | Pentagon Labs Limited |
| Shobhna Mittal DIN 00090516 | Director | 30 Sep 2005 | 21 yrs | Pentagon Labs Limited |
| Kashi Prasad Gupta DIN 08121521 | Director | 30 Apr 2018 | 8 yrs 6 mo | Pentagon Labs Limited |
| Anil Kumar Gupta DIN 02869053 | Whole-time director | 16 Jul 2020 | 6 yrs 3 mo | Pentagon Labs Limited |
People of Pentagon Labs
1 people are tracked at Pentagon Labs (1 in leadership).
| Name | Role | Group |
|---|---|---|
M L Jain | Founder | Leadership |
Complete people profiles for Pentagon Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Pentagon Labs
Figures of Pentagon Labs Limited, the primary company behind Pentagon Labs, for FY 2025. Revenue was ₹76.72 Cr (+8% year on year). Net profit was ₹5.07 Cr (7% margin). EBITDA was ₹9.78 Cr (13% margin). Revenue has grown at a compounded annual rate of +10% over three years and +6% over five years.
- ₹76.72 CrRevenue · FY 2025 · +8% YoY
- ₹5.07 CrNet profit · 7% margin
- ₹9.78 CrEBITDA · 13% margin
- ₹2.08 CrPaid-up capital
- +10%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pentagon Labs Limited are on its company page.
Detailed financial statements for Pentagon Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Pentagon Labs
3 dated milestones of Pentagon Labs across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Pentagon Labs is founded.
- Funding First funding round of $1.4M.
- Milestone Reaches Minicorn status.
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as Pentagon Labs (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 50.52 M | 902 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pentagon Labs
Complete news archive for Pentagon Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pentagon Labs
Pentagon Labs was founded in 2002 and raised its 1st funding round 12 years after it was founded.
Pentagon Labs is headquartered in Dewas, India. It is registered at Dewas, Madhya Pradesh, India.
Pentagon Labs is a funded company, having raised a total of $1.36M across 1 funding round to date. The company's 1st funding round was a Series A of $1.36M, raised on Mar 2014.
The primary company behind Pentagon Labs, Pentagon Labs Limited, reported revenue of ₹76.72 Cr for FY 2025, up 8% year on year.
Pentagon Labs research laboratory focused on developing manufacturing quality drugs formulations through providing healthcare solutions, and medical research labs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Pentagon Labs offers Infusion Therapy and Antibiotics and Antifungal.
Pentagon Labs has 5 investors. Key investors include Leo S M Finance, Mittal Warehousing and Cargo, Leo Corporate Consultants Indore, Shobhna Mittal, and Mahesh Chand Mittal.
The valuation of Pentagon Labs is $34.16M as of Mar 2014.
Pentagon Labs operates through Pentagon Labs Limited.
The legal entities of Pentagon Labs currently have 7 directors, including Kashi Prasad Gupta, Anil Kumar Gupta, Mahesh Chand Mittal and others.